Mizuho Maintains Outperform on DexCom, Raises Price Target to $95

Benzinga Newsdesk www.benzinga.com Positive 88.1%

Neg 0% Neu 0% Pos 88.1%

Mizuho analyst Anthony Petrone maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $90 to $95.